Segment Information by Division

For the Period January 1 to December 31

2014

  Download XLS

 

 

 

€ million

 

Silicones

 

Polymers

 

Biosolutions

 

Polysilicon

 

Siltronic

 

Other

 

Consolidation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

 

1,733.3

 

1,040.5

 

176.2

 

949.5

 

848.0

 

78.9

 

 

4,826.4

Internal sales

 

0.3

 

23.9

 

 

99.6

 

5.4

 

87.0

 

-216.2

 

Total sales

 

1,733.6

 

1,064.4

 

176.2

 

1,049.1

 

853.4

 

165.9

 

-216.2

 

4,826.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

128.9

 

118.7

 

13.6

 

305.3

 

-43.5

 

-75.4

 

-4.3

 

443.3

Depreciation and impairments / write-ups

 

80.9

 

30.8

 

10.0

 

231.7

 

157.5

 

88.1

 

 

599.0

EBITDA

 

209.8

 

149.5

 

23.6

 

537.0

 

114.0

 

12.7

 

-4.3

 

1,042.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

2.9

 

 

 

 

 

 

 

2.9

Impairment losses

 

 

 

 

 

-9.5

 

 

 

-9.5

Additions to property, plant and equipment1

 

88.5

 

56.3

 

8.4

 

334.5

 

40.7

 

43.8

 

 

572.2

Asset additions

 

88.5

 

56.3

 

8.4

 

334.5

 

40.7

 

43.8

 

 

572.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,255.1

 

546.4

 

145.7

 

2,620.7

 

1,044.1

 

1,535.1

 

-199.9

 

6,947.2

Liabilities (Dec. 31)

 

762.1

 

297.9

 

75.2

 

1,623.9

 

758.8

 

1,668.0

 

-185.2

 

5,000.7

Net assets (Dec. 31)

 

493.0

 

248.5

 

70.5

 

996.8

 

285.3

 

-132.9

 

-14.7

 

1,946.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in joint ventures and associates included in net assets (Dec. 31)

 

20.5

 

 

 

 

 

 

 

20.5

Research and development expenses

 

39.5

 

13.2

 

6.7

 

18.7

 

64.6

 

40.4

 

 

183.1

Employees (Dec. 31)

 

4,240

 

1,408

 

484

 

2,093

 

4,165

 

4,313

 

 

16,703

Employees (average)

 

4,201

 

1,400

 

476

 

2,083

 

4,263

 

4,321

 

 

16,744

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

  Download XLS

 

 

 

€ million

 

Silicones

 

Polymers

 

Biosolutions

 

Polysilicon

 

Siltronic

 

Other

 

Consolidation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

 

1,672.0

 

958.3

 

158.4

 

844.9

 

735.8

 

109.5

 

 

4,478.9

Internal sales

 

0.2

 

20.4

 

 

79.3

 

7.2

 

83.2

 

-190.3

 

Total sales

 

1,672.2

 

978.7

 

158.4

 

924.2

 

743.0

 

192.7

 

-190.3

 

4,478.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

151.1

 

112.9

 

17.2

 

0.1

 

-95.9

 

-73.1

 

2.0

 

114.3

Depreciation and impairments / write-ups

 

79.1

 

34.9

 

6.4

 

233.8

 

122.4

 

87.8

 

 

564.4

EBITDA

 

230.2

 

147.8

 

23.6

 

233.9

 

26.5

 

14.7

 

2.0

 

678.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

5.9

 

 

 

 

-42.5

 

 

0.5

 

-36.1

Impairment losses

 

 

 

 

-1.4

 

-34.8

 

-0.8

 

 

-37.0

Additions to property, plant and equipment1

 

85.4

 

36.8

 

10.2

 

290.0

 

30.9

 

50.4

 

 

503.7

Asset additions

 

85.4

 

36.8

 

10.2

 

290.0

 

30.9

 

50.4

 

 

503.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,186.9

 

481.2

 

116.1

 

2,331.9

 

1,095.6

 

1,500.4

 

-379.7

 

6,332.4

Liabilities (Dec. 31)

 

691.8

 

280.6

 

60.7

 

1,809.4

 

302.8

 

1,365.4

 

-375.4

 

4,135.3

Net assets (Dec. 31)

 

495.1

 

200.6

 

55.4

 

522.5

 

792.8

 

135.0

 

-4.3

 

2,197.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in joint ventures and associates included in net assets (Dec. 31)

 

18.9

 

 

 

 

 

 

 

18.9

Research and development expenses

 

34.6

 

12.3

 

7.0

 

20.6

 

59.2

 

43.4

 

-3.3

 

173.8

Employees (Dec. 31)

 

4,109

 

1,377

 

371

 

2,102

 

3,746

 

4,304

 

 

16,009

Employees (average)

 

4,110

 

1,377

 

371

 

2,126

 

3,806

 

4,344

 

 

16,134